BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients
BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients
Enrolling by invitation · NCT02051062 · Registry updated 2026-01-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients | Bacterial Infections and Mycoses, Chemically-Induced Disorders, Clostridium infectious disease, Foodborne Diseases, Infections, bacterial infectious disease, botulism, gram-positive bacterial infections, nervous system disorder, neuromuscular disease, neuromuscular junction disease, poisoning, toxic encephalopathy | Enrolling by invitation | Phase 4 | 2026-01-16 | NCT02051062 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Emergent BioSolutions | 7 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||